Which painkiller helps lungs recover better after sleeve gastrectomy?

NCT ID NCT07712224

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study looks at how two different ways of managing pain after laparoscopic sleeve gastrectomy affect lung function. One method uses an epidural catheter to deliver numbing medicine near the spine, while the other uses pain medicine given through an IV. Researchers measure breathing tests and pain scores to see which approach helps patients recover better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
epidural analgesia (bupivacaine and fentanyl) and intravenous analgesia (tramadol)
What this could lead to
If one method proves better for preserving lung function, it could guide pain management choices after weight-loss surgery.
What could go wrong
This is a small, retrospective study, so results may not apply to all patients. Differences in pain control or side effects could affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

106 people

The number who actually took part.

Started

Jan 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult obese patients undergoing laparoscopic sleeve gastrectomy at a tertiary training and research hospital.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients aged 18-65 years * ASA physical status III * Undergoing laparoscopic sleeve gastrectomy * Availability of preoperative and postoperative pulmonary function tests * Availability of arterial blood gas analysis data * Receipt of epidural or intravenous postoperative analgesia Exclusion Criteria: * Missing pulmonary function test data * Incomplete medical records * Conversion to open surgery * Severe respiratory disease affecting pulmonary function assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bariatric surgery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Trabzon Kanuni Training and Research Hospital

    Trabzon, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.